Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
KDA Group Inc. ( (TSE:KDA) ) just unveiled an update.
KDA Group Inc. has announced a partnership with CHU de Québec – Université Laval to deploy its Medherize platform at Hôpital du Saint-Sacrement. This platform supports breast cancer patients undergoing complex oral treatments by improving coordination between hospital teams and community pharmacists. The partnership is expected to expand the solution to other hospitals in Quebec, Canada, and internationally, enhancing patient care and optimizing the management of specialty medications. The collaboration has generated interest from pharmaceutical companies and pharmacy chains, indicating significant opportunities for KDA’s business model.
More about KDA Group Inc.
KDA Group Inc. is a leader in technological innovations and specialized software solutions for the healthcare professionals’ market. The company offers high-quality products and has recognized expertise in the pharmaceutical and medical sectors. KDA aims to accelerate healthcare’s digital transformation with its technology products available for Canadian and international markets.
Average Trading Volume: 72,945
Technical Sentiment Signal: Buy
Current Market Cap: C$49.58M
Learn more about KDA stock on TipRanks’ Stock Analysis page.